Qube Research & Technologies (QRT)
GPCR icon

Qube Research & Technologies (QRT)’s Structure Therapeutics GPCR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.01M Buy
93,403
+19,804
+27% +$876K ﹤0.01% 1627
2026
Q1 		$3.55M Buy
+73,599
New +$5.04M ﹤0.01% 1838
2024
Q2 		– Sell
-7,165
Closed -$307K – 4156
2024
Q1 		$307K Sell
7,165
-33,511
-82% -$1.41M ﹤0.01% 2796
2023
Q4 		$1.66M Buy
+40,676
New +$2.33M ﹤0.01% 1632

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GPCR Position: Q2 2026 in Review

Qube Research & Technologies (QRT) increased its Structure Therapeutics (GPCR) stake by 27% in Q2 2026, buying an estimated $876K and bringing the position to 93,403 shares worth $5.01M. The position accounts for ﹤0.01% of the portfolio, ranked #1627.

Qube Research & Technologies (QRT) first reported a position in GPCR in Q4 2023 and has held it in 4 quarters since. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Qube Research & Technologies (QRT) held 93,403 shares of Structure Therapeutics worth $5.01M as of Q2 2026.
  • Qube Research & Technologies (QRT) bought 19,804 Structure Therapeutics shares in Q2 2026, an estimated $876K.
  • Structure Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #1627 holding.
  • Qube Research & Technologies (QRT) first reported a position in Structure Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.